| Database: Ovid MEDLINE(R) <1950 to January Week 3 2009> | |
| KEY QUESTIONS 2, 3 | |
| Search Strategy: | |
| 1 | exp Tamoxifen/ae, po, ct, to [Adverse Effects, Poisoning, Contraindications, Toxicity] |
| 2 | exp Raloxifene/ae, ct, to [Adverse Effects, Contraindications, Toxicity] |
| 3 | Selective Estrogen Receptor Modulators/ae, co, to, po |
| 4 | 1 or 2 or 3 |
| 5 | exp Cardiovascular Diseases/mo, ci, co, ep, et [Mortality, Chemically Induced, Complications, Epidemiology, Etiology] |
| 6 | exp Stroke/mo, co, ci, ep, et |
| 7 | exp Cardiovascular System/pp, de |
| 8 | 5 or 6 or 7 |
| 9 | 4 and 8 |
| 10 | exp Cardiovascular System/ |
| 11 | exp Cardiovascular Diseases/ |
| 12 | 10 or 11 |
| 13 | exp Tamoxifen/ |
| 14 | exp Raloxifene/ |
| 15 | Selective Estrogen Receptor Modulators/ |
| 16 | 13 or 14 or 15 |
| 17 | 4 and 12 |
| 18 | 8 and 16 |
| 19 | 17 or 18 |
| 20 | limit 9 to humans |
| 21 | limit 19 to humans |
| 22 | 21 not 20 |
| 23 | 12 and 16 |
| 24 | limit 23 to humans |
| 25 | 24 not 21 |
From: Appendix A, Searches
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.